Rapport Therapeutics (RAPP) Shares Issued (2024 - 2026)
Rapport Therapeutics (RAPP) reported Shares Issued of $809000.0 for Q1 2026, up 13383.33% year-over-year from N/an in Q1 2025, and up 14.59% quarter-over-quarter from $706000.0 in Q4 2025.
Rapport Therapeutics (RAPP) Shares Issued (2024 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 3 years of Shares Issued data on file, last reported at $809000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $809000.0, up 13383.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 254.97% YoY), and the FY2025 annual result was $1.3 million, down 99.15% from the prior year.
- Shares Issued advanced to $809000.0 in Q1 2026 per RAPP's latest filing, from $706000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $809000.0 in Q1 2026 and troughed at -$1.4 million in Q3 2024.
- A 3-year average of $152600.0 and a median of $636000.0 in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2025 and 2026: Shares Issued surged 145.62% in 2025, then soared 13383.33% in 2026.
- A 3-year view of Shares Issued shows it stood at -$1.4 million in 2024, then jumped by 150.65% to $706000.0 in 2025, then grew by 14.59% to $809000.0 in 2026.
- Business Quant data shows RAPP's Shares Issued at $809000.0 in Q1 2026, $706000.0 in Q4 2025, and $636000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26,927.15 |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | 809,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 809,000.00 |
| Mar 31, 2026 | 809,000.00 |
| Dec 31, 2025 | 706,000.00 |
| Dec 31, 2025 | 706,000.00 |
| Sep 30, 2025 | 636,000.00 |
| Sep 30, 2025 | 636,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Sep 30, 2024 | -1.39 Mn |
| Sep 30, 2024 | -1.39 Mn |